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Human cystic echinococcosis (hydatidosis) is a parasitic zoonosis with almost complete worldwide
distribution. Echinococcus granulosus, the dog tapeworm, causes hydatidosis which accounts for 95% of
human echinococcosis. Although this tapeworm is found in dogs as a deﬁnitive host and a number of
intermediate hosts, humans are often infected from close contact with infected dogs. Humans are not
part of the parasitic lifecycle and serve as accidental hosts. Hydatidosis is an important consideration in
the differential diagnosis of hepatic cysts in individuals from endemic areas. Clinicians should be aware
of the long incubation period, the high frequency of negative serological tests, and the possibility of
intraoperative evaluations of the cyst aspirate being non-diagnostic. We describe a case of serology
negative hydatidosis that came to medical attention as an incidental ﬁnding in a young woman from
Bangladesh. The patient underwent imaging and was then started on albendazole. After several weeks of
albendazole, the cyst was punctured, aspirated, injected with hypertonic saline, re-aspirated, and then
fully excised. Diagnosis was conﬁrmed by microscopic evaluation of the cyst aspirate. Serological tests
for hydatidosis may be negative in patients with early disease and thus should not be used to rule out this
disease. Consideration of this diagnosis allows clinicians to avoid the catastrophic spillage of cystic
contents risking an anaphylactic reaction, which might prove fatal. Despite World Health Organization
hydatidosis staging being based on ultrasound, radiologists in resource-rich setting may prefer MRI in
the management and staging of cystic echinococcosis.
ß 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

Introduction
Human cystic echinococcosis is a parasitic zoonosis caused by
the larval form of Echinococcus granulosus, the dog tapeworm,
which accounts for 95% of human echinococcosis cases. Human
cystic echinococcosis is present worldwide except in Iceland,
Ireland, and Greenland, and remains highly endemic in many
rural communities [1]. In developed countries, such as the United
States, this is mainly a disease of immigrants although there has
been reported local transmission to humans in California, Arizona,
New Mexico, Utah and Alaska [2,3]. Cystic echinococcosis has a
mortality of 2–4% and may be more common in the United States

* Corresponding author at: Department of Infectious Disease, Hofstra North
Shore-LIJ School of Medicine, 400 Community Drive, Manhasset, NY 11030, USA.
Tel.: +1 516 562 4280.
E-mail address: dgrifﬁn3@nshs.edu (D.O. Grifﬁn).

than generally recognized, in part because the disease is not
reportable [4,5]. Worldwide, echinococcosis causes an estimated
annual loss of US $194,000,000 or 285,000 disability-adjusted life
years [1].
Hydatidosis is usually transmitted by the unintentional
ingestion by humans of food or water contaminated with fecal
material from infected canines. The tapeworm inhabits the small
intestine of canines, the deﬁnitive host, and may release thousands
of embryonated eggs in the feces each day. The viability of these
eggs may exceed 1 year when deposited into a cool, moist
environment. When ingested, these eggs hatch in the small
intestine releasing an oncosphere which matures into a metacestode. The metacestodes penetrate the bowel wall and migrate via
the circulatory system to a number of organs including but not
limited to the liver [6–8]. In the liver, or other organ to which the
parasite migrates, a cyst develops, enlarges, becomes ﬁlled with
protoscoleces and daughter cysts and undergoes a predictable
evolution over a number of years with characteristic imaging
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features [9]. The cysts tend to increase in size by about 1–5 cm per
year with calciﬁcation occurring 5–10 years post infection, but this
development varies depending on the individual infected as well as
the particular genotype of the infecting parasite [10,11].
In areas of the world where hydatidosis is endemic, control
programs have been established to eradicate it by interrupting the
zoonotic cycle, through the use of health education, meat
inspection, dog testing, dog treatment, and in some cases largescale canine culling [12]. Although ‘‘Island’’ control programs have
been successful in Iceland, New Zealand, Tasmania, Falklands and
Cyprus, outcomes for ‘‘Continental’’ control programs, in Africa,
Asia and South America, have not been as favorable. If the efﬁcacy
and feasibility of canine vaccination, which is currently being
tested, are established, ‘‘Continental’’ programs will have an
increased chance of success [13,14].
Imaging often plays a large role in the diagnosis of this disease,
but despite the greater than 90% sensitivity of ultrasound for
hepatic hydatidosis there often is a challenge in distinguishing
between an echinococcal cyst and a simple liver cyst [15]. A
number of serological tests are available for echinococcal disease
including IgG ELISA, but these tests have less than optimal
sensitivity and issues with speciﬁcity [16,17]. Accurately distinguishing an echinococcal cyst from a simple cyst is critical in the
management of these infected patients because approximately
10% of the time, the accidental leakage of hydatid cyst contents
into the abdominal cavity results in an often fatal anaphylactic
reaction [18,19].

Fig. 1. Abdominal computed tomography scan. This is a representative slice from
the CT performed during the initial patient hospitalization with the following
details. Procedure date: February 23, 2013. Findings: there is a heterogeneous
hypoattenuating mass in the liver (8.4 cm  5 cm  5.2 cm). Impression: benign
versus malignant neoplasm versus hamartoma versus adenoma, less likely
hepatocellular carcinoma, no cirrhosis.

Case presentation
A 29-year-old immigrant from Bangladesh was admitted to Long
Island Jewish Hospital in February 2013 with fever, abdominal pain
and chills. This young woman was married with two young children
and had a past medical history of migraines treated with
sumatriptan as needed, a benign ovarian cyst, and a prior episode
of nephrolithiasis. She had grown up in rural Bangladesh where her
family raised livestock. She moved to the United States in 2008, at
the age of 24 years, and had returned to Bangladesh only once when
she visited her family in January 2010. The patient reported contact
with her family’s dogs while in Bangladesh. Upon admission, she was
diagnosed with inﬂuenza B on the basis of symptoms and a positive
polymerase chain ampliﬁcation test from a respiratory viral panel
test. Although the patient’s immediate symptoms resolved after
several days without any speciﬁc therapy, an abdominal computed
tomography (CT) scan was performed as part of the evaluation of her
abdominal pain.
The abdominal CT scan revealed a heterogeneous hypoattenuating mass in the liver (8.4 cm  5 cm  5.2 cm) (Fig. 1). A
magnetic resonance imaging (MRI) scan of the liver suggested
that this was a complex cyst, without surrounding edema, showing
numerous serpiginous septations. The MRI was read as most likely
an echinococcal cyst (Fig. 2). After several days in the hospital the
patient was discharged from the acute care setting and was
scheduled for follow-up care in the outpatient setting. A number of
tests were ordered including an echinococcal ELISA.
The patient was seen in the outpatient clinic several weeks
later, in the beginning of April, and noted to have a negative
echinococcal IgG ELISA. Despite this negative test the clinical
suspicion was high enough that the patient was started on
albendazole and a repeat imaging test was ordered. In the
beginning of May, a repeat MRI was performed that documented
no change in the liver cyst.
The patient was admitted for surgery following the second MRI.
The cyst was punctured and the ﬂuid aspirated. A portion of the
ﬂuid was sent for immediate microscopic evaluation, performed at
the time of surgery, and the remaining ﬂuid was sent to the

Fig. 2. Magnetic resonance scan of upper abdomen with and without contrast. This
is a representative slice from the MRI performed during the initial patient
hospitalization with the following details. Procedure date: February 24, 2013.
Findings: there is a nonenhancing complex cystic lesion in segment 8 of the liver,
which contains numerous serpiginous internal septations, small foci of fat and ﬂuid.
No additional lesions identiﬁed. There is no evidence of intra or extra biliary ductal
dilation. The gall bladder is normal. The pancreas, adrenals, and kidneys and spleen
are unremarkable. No contrast extravasation into the cyst is seen on the hepatocyte
phase images. There is no mesenteric or retroperitoneal lymphadenopathy. The
visualized bowel is unremarkable. Impression: cystic liver lesion containing small
foci of fat is most likely an echinococcal cyst.

diagnostic parasitology division of the NSLJHS Core Lab. The cyst
was injected with 20% hypertonic saline and then, after a 10-min
dwell time, reaspirated. The cyst was then opened and explored. At
the time of surgery, only a simple cyst was evident with no
septations; no smaller cysts and no obvious daughter cysts were
noted. The cyst was then fully excised with no complications. The
patient tolerated the procedure well and was discharged to home
after her hospital stay to complete a several month course of
albendazole. Evaluation of the cyst contents in the parasitology lab
revealed numerous hooklets in the aspirated ﬂuid conﬁrming the
diagnosis of an echinococcal cyst.
Discussion
There are a number of features of this case of human hepatic
hydatidosis that make it both interesting and challenging for the
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clinician. The travel and exposure history, the negative serology
and the negative microscopic evaluation of the cyst contents
reported during the time of surgery are three aspects that deserve a
bit more attention.
Since certain parasitic diseases are characterized by long
incubation periods between exposure and disease or diagnosis,
an extensive travel and exposure history is required to be taken by
the clinician in order to introduce infection with E. granulosus, the
dog tapeworm, into the differential diagnosis. On initial history
this patient was noted to be a young woman living in the urban
environment of Queens, New York, with no travel within the last 3
years and no exposure to pets or other animals. A deeper
exploration of this woman’s past history revealed that she was
born and raised in a rural part of Bangladesh where her family was
involved in animal husbandry and she was exposed to dogs. This
woman had moved out of this environment 5 years previously, but
just over 3 years prior to this liver cyst coming to medical attention
she had traveled back to visit her family in the endemic area. With
the very variable course of E. granulosus it is not possible to be
certain whether her infection was acquired during her return to
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Bangladesh in January 2008 or whether this was acquired prior to
her emigrating to the US, although the stage of the cyst would favor
infection during her January 2008 visit. In addition to the long
period between exposure and diagnosis is the fact that this woman
falls into the identiﬁed high-risk group of international traveler
termed traveler visiting friends and relatives (VFRs). Even an
adventurous traveler to a destination is unlikely to have the
exposure that this woman had upon visiting her family’s home and
directly interacting with the family dogs.
Despite the history and other features of the case being so
compelling, the negative serology for echinococcal disease is an
important feature in this case. A number of the neglected diseases
(NTDs), less common in the developed world, have diagnostic
assays lacking the high level of sensitivity of many ELISAs
commonly ordered in these areas. A negative serology does not
rule out cystic echinococcosis (CE) as clearly demonstrated in this
case. Not only may a patient have an echinococcal cyst with a
negative serology, but there may also not be a consistent
relationship between the extent of the infection and serological
results [20,21]. In some series 30–40% of patients with hepatic

Fig. 3. Appearance, classiﬁcation of cyst stage, cyst stage description and recommended treatments for echinococcal cysts.
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cystic echinococcosis are antibody negative and this may be due to
the ability of E. granulosus antigens to inhibit B cell activity and
proliferation [22]. Although the sensitivity of serological testing is
not clearly dependent on the extent of disease, it does appear to be
dependent on cyst stage. Patients with cystic echinococcosis can be
staged according to the WHO criteria and may fall in the spectrum
between CE1 and CE5 (Fig. 3) [23]. Patients with early or inactive
cyst stages may only have positive serologies as little as 54.8%, and
patients with simple cysts staged at CE1 may only be positive 73.7%
of the time [24]. The sensitivity of the ELISA increases for patients
with active disease staged as CE2 and CE3.
We used an echinococcal IgG ELISA, which in our lab reﬂexes to
a conﬁrmatory Western blot when positive. This test has perhaps
the highest positive predictive value among the available
serological tests, but unfortunately may only have a negative
predictive value of <90% [20]. One possible approach to a
compelling clinical case with negative IgG ELISA is to perform
several serological tests using different modalities such as indirect
hemagglutination, latex agglutination, immunoelectrophoresis, or
radioallergosorbent testing. It has been demonstrated that since
the size, location and clinical stage of the cyst affect the accuracy of
the various serological tests, a combination of several tests can
improve diagnostic accuracy [20]. One might also consider
repeating the same serological test at different laboratories as
change in sensitivities can occur due to the batch-to-batch
variation in the prepared antigens [25]. Due to the limitations of
current serological assays, a number of researchers are actively
investigating the use of speciﬁc echinococcal peptides and
echinococcus protoscolex soluble somatic antigens (PSSAs). The
use of speciﬁc echinococcal peptides and echinococcus PSSAs may
increase our sensitivity and speciﬁcity and even allow staging of
the disease with serological rather than imaging tests [26]. In our
case, we chose to proceed with a clinical diagnosis of cystic
echinococcosis despite the negative serology, considering that
further testing would not have changed our planned management.
In this woman’s case, microscopic ﬂuid evaluation during the
surgical procedure was unrevealing and there was no reported
visualization of protoscoleces, hooklets or fragments of laminated
membrane. Visualizing diagnostic hydatid elements in wet,
unstained mounts of cystic ﬂuid sediment is challenging and time
consuming; thus researchers are searching for potentially superior
techniques such as rapid antigen detection assays [27,28]. Our
Institution’s access to a parasitology laboratory with technicians
experienced in the identiﬁcation of hydatid ﬂuid sediment was
critical for the correct diagnosis and appropriate management of
this patient. At institutions without access to a parasitology lab,
clinicians should refer patients with possible hydatidosis to a
center with such access if hydatidosis diagnosis would be critical in
the proper care of the patient.
Critical to the successful outcome in this case was that, despite
the distant history of exposure, the negative serology, and the
negative microscopic examination during the time of surgery, the
patient was still optimally treated. The patient was pretreated with
albendazole, the cyst was properly aspirated without leakage, a
protoscolicide (hypertonic saline) was injected, with an appropriate dwell time, and then the cyst was re-aspirated prior to surgical
removal. Optimal management of cystic echinococcosis is guided
by cyst stage and an expert consensus for guiding the clinical
management of these patients has been generated under the aegis
of the World Health Organization Informal Working Group on
Echinococcosis (WHO-IWGE) [23]. The appearance, classiﬁcation
of cyst stage, description and recommended treatments are
presented in Fig. 3. Every effort should be made to prevent
protoscolex spillage and sterilize the germinal layer as the
mortality rate of 2–4% usually seen in cases of cystic echinococcus
may be increased if patients are improperly treated. Spillage of

viable protoscoleces from a cyst may result in anaphylaxis,
secondary cystic echinococcus or death.
Despite the staging of echinococcal cysts being based on
ultrasound characteristics of the identiﬁed cysts, in developed
countries, CT scans and MRI scans may be selected by the clinicians
responsible for the management of these patients. Following an
initial CT, this patient underwent two MRI scans, the ﬁrst to further
characterize the cyst and the second to evaluate any change in the
cyst. It is suggested that MRI is superior to CT in reproducing the
ultrasonic features and heavily T2-weighted MRI series may even
be superior to ultrasound for certain cyst location or patientspeciﬁc reasons [2].
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